ConductScience.org, home

Paper4594599

Cellular hypersensitivity to breast cancer. Assessment by a leukocyte migration procedure.

Black MM and 3 others. Cancer, 1974. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. Cellular hypersensitivity to breast cancer. Assessment by a leukocyte migration procedure. Papers, record 4594599. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4594599

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cellular hypersensitivity to breast cancer. Assessment by a leukocyte migration procedure.
PubMed
Journal
Cancer
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
3.21
iCite
Revised in PubMed
2019-06-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Black MMM M
2Leis HP JrH P
3Shore BB
4Zachrau RER E

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Hypersensitivity, DelayedMajor topic
Immunity, CellularMajor topic
Carcinoma in Situ
Cell Migration Inhibition
Cross Reactions
Female
Humans
Skin Window Technique

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
7180599Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.Acta Neurochir (Wien)1982https://conductscience.org/library/papers/7180599PubMed
7035728Reactivity of gastric cancer patients in leucocyte migration inhibition tests to 3M KCl extracts from gastric tumor.Jpn J Surg1981https://conductscience.org/library/papers/7035728PubMed
6628918Immunoassessment of patients with gastric cancer. Using leukocyte migration inhibition (LMI) test.Gastroenterol Jpn1983https://conductscience.org/library/papers/6628918PubMed
6365132Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.Br J Cancer1984https://conductscience.org/library/papers/6365132PubMed
6176752Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.Klin Wochenschr1982https://conductscience.org/library/papers/6176752PubMed
962394Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.Ann Surg1976https://conductscience.org/library/papers/962394PubMed
877116Immunological tests in carcinoma of the prostate.Proc R Soc Med1977https://conductscience.org/library/papers/877116PubMed
736631[Cell mediated immunity in cervical cancer patients: evaluation by in vitro leukocyte-migration-inhibition-assay (author's transl)].Arch Gynecol1978https://conductscience.org/library/papers/736631PubMed
723017Cellular hypersensitivity to autologous tumor extract in patients with breast carcinoma.Jpn J Surg1978https://conductscience.org/library/papers/723017PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4594599

GET https://conductscience.org/api/papers/v1/4594599/authors